LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Abbott Diagnostics Displays Alinity Family of Systems

By LabMedica International staff writers
Posted on 02 Aug 2018
Image: The Alinity on display at AACC 2018 (Photo courtesy of Abbott).
Image: The Alinity on display at AACC 2018 (Photo courtesy of Abbott).
Abbott Diagnostics (Abbott Park, IL, USA) displayed the Alinity next-generation family of systems at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois, USA. The Alinity harmonized family of systems across key laboratory disciplines is designed to simplify diagnostics and help deliver results that drive better patient outcomes.

Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostics platforms and simplify diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.

The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott's AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics.

The Alinity ci-series combines the power of integrated clinical chemistry and immunoassay systems in unprecedented, innovative combinations to meet every laboratory's needs. The Alinity h-series solution integrates the Alinity hq with the Alinity hs slide maker and stainer module into a combined solution for hematology testing. The Alinity h-series solution is 20% faster per m2 than other currently available integrated hematology systems with a throughput of 133 complete blood counts (CBCs) per m2.

The Alinity m molecular system addresses operational complexities, such as increasing the capacity for growth, improving workflow efficiencies and reducing demand on labor. The Alinity s system for blood and plasma screening is designed to screen blood and plasma faster and more efficiently within a smaller footprint, helps blood and plasma centers improve productivity and maintain the highest levels of accuracy, without expanding the instrument footprint.

The Alinity PRO software works with all Alinity systems to fully maximize their potential and enhance operational productivity throughout the network, allowing for easier and consolidated system monitoring anytime, anywhere. And with predictive system monitoring through AlinIQ Always On, Abbott’s professional services can proactively monitor the health of these systems and help avoid unexpected downtime.

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
8-Channel Pipette
SAPPHIRE 20–300 µL

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more